May 21, 2018 Columns by Ed Tobias MS News that Caught My Eye Last Week: PML Treatment, Gilenya for Kids, Rituximab, and an MS trial that is Enrolling Complications from Gilenya Treatment Managed Successfully, Case Report Says This wasn’t a minor complication. It was a version of PML, a brain disease that can be fatal. PML is also a known side effect of Tysabri, so the report of a successful treatment should be important to…
May 18, 2018 Columns by Ed Tobias A Pediatric MS Medication Gets the OK Until about a week ago, no medication was approved in the U.S. to treat patients with pediatric-onset MS (POMS). Now there is one. The Food and Drug Administration (FDA) has given its OK to use Gilenya (fingolimod) to treat relapsing MS in children and adolescents starting at…
May 8, 2018 News by Alice MelĆ£o, MSc Rituximab Seen to Ably and Safely Treat Refractory RRMS Patients in French Study An approved lymphoma treatment,Ā rituximab was found to be effective and safe for relapsing-remitting multiple sclerosis (RRMS) patients whose active disease has failed to respond to immunosuppressive therapies, a retrospective French study reports. Published in the Multiple Sclerosis Journal in an article titled, āEfficacy of…
April 30, 2018 Columns by Ed Tobias MS News that Caught My Eye This Week: aHSCT Studies, MS Progression in African-Americans, Gilenya for Pediatrics #AAN2018 ā Stem Cell Transplant is Effective Treatment for āAggressiveā MS, Study Shows I like the fact that a study shows that stem cell transplant treatment is effective for aggressive MS. I love the fact that the efficacy was dramatic, reducing theĀ Expanded Disability Status Scale (EDSS) levels…
March 5, 2018 Columns by Ed Tobias MS News that Caught My Eye Last Week: Epstein-Barr Virus, Gilenya, Naltrexone, Medical Marijuana Epstein-Barr Virus Found in Brain Cells of Many MS Patients, Study Reports This study is yet another of several over the years that have suggested that there’s some sort of link between the Epstein-Barr virus and multiple sclerosis (MS). (Fatigue and muscle weakness are among the…
January 29, 2018 Columns by Ed Tobias MS News that Caught My Eye Last Week: Medical Marijuana Gum, Brain Stimulation and Fatigue, Gilenya Study, Invisible Diseases Holland Approves Clinical Trial Plans for AXIMās Cannabis-based Gum for MS Pain and Spasticity Because the state where I live has only recently approved the use of medical marijuana, I haven’t had the opportunity to try it for my MS. From what I’ve read, various blends of…
September 11, 2017 Columns by Ed Tobias MS News That Caught My Eye Last Week: Women vs. Men, Epstein-Barr, Mavenclad, Gilenya Older Women with MS Age Better Than Their Male Counterparts, Canadian Survey Finds I have to say that, as a 69 year old man with MS, this report is a bit depressing. In fact, one of its findings is that older men are depressed while older women…
August 2, 2016 News by Patricia Silva, PhD Gilenya Seen as Most Effective in Younger and Previously Untreated Patients with Relapsing MS A study analyzing results from three Phase 3 clinical trials shows that Gilenya (fingolimod) effectively prevents relapses in different types of relapsing multiple sclerosis (MS) patients, with the therapy being most efficient in younger patients and those withoutĀ previous treatment. The findings highlight the importance of starting treatment early, and not…